| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2007 | 2019 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
calreticulin | 0.413 | 0.923 | 0.89 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2016 | ||||||||
|
mannose receptor C-type 1 | 0.413 | 0.846 | 0.94 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
TNF superfamily member 10 | 0.413 | 0.885 | 0.13 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 1 | 2018 | 2018 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2019 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
cyclin dependent kinase inhibitor 2B | 0.417 | 0.769 | 7.3E-03 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2001 | 2018 | ||||||||
|
mitogen-activated protein kinase kinase 7 | 0.419 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
WT1 transcription factor | 0.422 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 28 | 0 | 1994 | 2018 | ||||||||
|
interleukin 15 | 0.422 | 0.846 | 0.71 |
|
phenotype | 0.020 | None | 1.000 | 2 | 1 | 2009 | 2016 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 1 | 0.424 | 0.808 | 2.6E-12 |
|
phenotype | 0.050 | None | 1.000 | 5 | 1 | 2014 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
phenotype | 0.100 | None | 0.953 | 43 | 0 | 1993 | 2019 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
CD19 molecule | 0.430 | 0.885 | 0.90 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 2000 | 2019 | ||||||||
|
Fas ligand | 0.430 | 0.885 | 0.18 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
MCL1 apoptosis regulator, BCL2 family member | 0.430 | 0.808 | 0.96 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 35 | 0 | 1990 | 2020 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 76 | 0 | 1992 | 2019 | ||||||||
|
isocitrate dehydrogenase (NADP(+)) 2 | 0.434 | 0.808 | 0.88 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 |